Dr. Kim Dong-Wook CML Chronic Myeloid Leukemia
Professor, Division of Hematology, St. Mary’s Hospital, The Catholic University of Korea;
Director, Molecular Genetic Research Laboratoy, Catholic Medical Science Institute, The Catholic University of Korea;
Director, Asia-Pacific Central Referral
Laboratory of Novartis Global Clinical Trials:
Director, Molecular Genetic Research Laboratoy, Catholic Medical Science Institute, The Catholic University of Korea;
Director, Asia-Pacific Central Referral
Laboratory of Novartis Global Clinical Trials:
''A research team at Seoul St. Mary's Hospital's hematopoetic stem cell transplant center, led by professor Kim Dong-Wook, administered the new medicine, named Supect (IY5511), to 22 chronic myeloid leukemia patients from July 2008''... Extract from Youhp
ARTICLES
CML update from 2011 ASH annual meeting
December 14, 2011, Biotech Strategy Blog
Recent advances in the path toward the cure for chronic myeloid leukemia
September 30, 2011, The Korean Journal of Hematology
New Leukemia Drug Shows Promise
July 30, 2009, Korea Times
CML update from 2011 ASH annual meeting
December 14, 2011, Biotech Strategy Blog
Recent advances in the path toward the cure for chronic myeloid leukemia
September 30, 2011, The Korean Journal of Hematology
New Leukemia Drug Shows Promise
July 30, 2009, Korea Times